225 related articles for article (PubMed ID: 7025032)
1. History of pharmacokinetics.
Wagner JG
Pharmacol Ther; 1981; 12(3):537-62. PubMed ID: 7025032
[No Abstract] [Full Text] [Related]
2. COMPT, a time-sharing program for nonlinear regression analysis of compartmental models of drug distribution.
Pfeffer M
J Pharmacokinet Biopharm; 1973 Apr; 1(2):137-63. PubMed ID: 4271775
[No Abstract] [Full Text] [Related]
3. Pharmacokinetics and bioavailability.
Wagner JG
Triangle; 1975; 14(3-4):101-8. PubMed ID: 1209729
[No Abstract] [Full Text] [Related]
4. [Application of pharmacokinetics in clinical pharmacology and biopharmaceutics].
Xi NZ
Yao Xue Xue Bao; 1983 Feb; 18(2):151-60. PubMed ID: 6613595
[No Abstract] [Full Text] [Related]
5. [Pharmacokinetic aspects relevant to biopharmaceutics].
Segre G
Ann Ist Super Sanita; 1982; 18(3):533-40. PubMed ID: 7187841
[No Abstract] [Full Text] [Related]
6. [Biological availability of drugs].
Holovkin VO
Farm Zh; 1979; (2):20-5. PubMed ID: 456507
[No Abstract] [Full Text] [Related]
7. Linear systems analysis in pharmacokinetics.
Cutler DJ
J Pharmacokinet Biopharm; 1978 Jun; 6(3):265-82. PubMed ID: 671230
[No Abstract] [Full Text] [Related]
8. [Clinical value of the determination of drugs in the blood: a new aspect of pharmacokinetics].
Hirtz J; Schoeller JP
Nouv Presse Med; 1976 Mar; 5(13):869-72. PubMed ID: 1264634
[No Abstract] [Full Text] [Related]
9. A history of biopharmaceutics in the Food and Drug Administration 1968-1993.
Skelly JP
AAPS J; 2010 Mar; 12(1):44-50. PubMed ID: 19936940
[TBL] [Abstract][Full Text] [Related]
10. [Methodological approach to the measure of the bioavailability of drugs in man (author's transl)].
Lesne M
J Pharm Belg; 1976; 31(1):5-24. PubMed ID: 768445
[No Abstract] [Full Text] [Related]
11. Clearance concepts in pharmacokinetics.
Rowland M; Benet LZ; Graham GG
J Pharmacokinet Biopharm; 1973 Apr; 1(2):123-36. PubMed ID: 4764426
[No Abstract] [Full Text] [Related]
12. A model-independent proof of Dost's law of corresponding areas.
Vaughan DP
J Pharmacokinet Biopharm; 1977 Jun; 5(3):271-6. PubMed ID: 881645
[No Abstract] [Full Text] [Related]
13. Literature growth in pharmacokinetics.
Boxenbaum H
J Pharmacokinet Biopharm; 1982 Jun; 10(3):335-48. PubMed ID: 7175703
[TBL] [Abstract][Full Text] [Related]
14. Bioavailability and pharmacokinetic analysis of drug responding systems.
Smolen VF
Annu Rev Pharmacol Toxicol; 1978; 18():495-522. PubMed ID: 348066
[No Abstract] [Full Text] [Related]
15. Parameter estimation for the one compartment open model.
McMillan I; Minder CE
Comput Biomed Res; 1981 Jun; 14(3):232-9. PubMed ID: 7285552
[No Abstract] [Full Text] [Related]
16. A rotating iterative procedure (RIP) for estimating hybrid constants in multi-compartment analysis on desk computers.
von Hattingberg HM; Brockmeier D; Kreuter G
Eur J Clin Pharmacol; 1977; 11(5):381-8. PubMed ID: 880977
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacokinetic models].
Dahl S
Tidsskr Nor Laegeforen; 1973 Jan; 93(3):157-62. PubMed ID: 4693373
[No Abstract] [Full Text] [Related]
18. [A pharmacokinetic function for galenics].
Dost FH
Arzneimittelforschung; 1971 May; 21(5):712-7. PubMed ID: 5109699
[No Abstract] [Full Text] [Related]
19. Absolute drug bioavailability II: Evaluation of renal clearance perturbation method using literature data assuring a fraction absorbed of unity.
Lalka D; du Souich P; McLean AJ; Gibaldi M
J Pharm Sci; 1978 Apr; 67(4):591-2. PubMed ID: 641784
[No Abstract] [Full Text] [Related]
20. The simulation of the elimination process for a substance injected into the blood stream.
Hallberg D; McLean A
Acta Med Scand; 1973; 194(3):173-9. PubMed ID: 4746525
[No Abstract] [Full Text] [Related]
[Next] [New Search]
